Campylobacter strains, and 8 strains of Aeromonas hydrophila, previously reported to produce cholera toxin-like toxin, were all negative in the ctxA PCR. We conclude that this PCR is a diagnostic method that specifically detects toxin genes in V. cholerae 01 strains in a reference laboratory. It is more rapid and less cumbersome than other diagnostic methods for detection of toxicity in these strains.
identical elements responsible for binding to the epithelial cell surface receptor, GM1. The genes expressing A and B subunits are designated ctxA and caxB, respectively. They are expressed as a single transcriptional unit, and the structural genes overlap by one base (11) .
Molecular epidemiologic approaches have been essential in documenting the spread of cholera throughout the Americas, and this technology has promise as the basis for a new generation of diagnostic assays for this increasingly important pathogen (1, 17, 18) . In this article, we describe the development and evaluation of a polymerase chain reaction (PCR) that amplifies ctxA, and we present data generated from its use in the current outbreak of cholera in the Americas.
MATERIALS AND METHODS
Strains and templates. One hundred and forty-nine isolates of V. cholerae 01 found in investigations of outbreaks of cholera in 1991, mainly in Latin America and the United States, were studied (Table 1 ). In addition, a collection of 38 toxigenic and 18 nontoxigenic V. cholerae 01 strains isolated over the last 60 years were used as reference material (Tables 2 and 3 ). Thirty-five Escherichia coli strains of different serotypes and origins, previously shown to produce heat-labile enterotoxin (LT), eight Aeromonas hydrophila strains, and 26 Campylobacter jejuni and Campylobacter coli strains that have been reported to produce a cholera toxin-like toxin (3, 10, 14, 16) (15) . For control purposes, reaction mixtures containing distilled water and all other reagents but no template were included. The thermocyclers and the pipettes used for preparing the PCR reagents were kept in a different location from where gels were loaded and stained and pictures were taken. All reagents used in one experiment were taken in aliquots from the freezer and discharged at the end of the day.
Samples (15 ,ul) of the amplified DNA were purified by using a CL6B Sephadex spin column and digested by using either RsaI or AluI (as described by the manufacturer, Bethesda Research Laboratories). The fragments were separated on a 0.8% acrylamide gel at 60 V for 3 h. Digesting the 564-bp cixA amplicon with RsaI resulted in three fragments, 480-, 70-, and 10-bp fragments (the last one is not visible on the gel). Digestion with AluI resulted in two fragments, 500-and 65-bp fragments.
ELISA for cholera toxin. All V. cholerae strains were tested for cholera toxin production in an enzyme-linked immunosorbent assay (ELISA) which is described in detail elsewhere (2, 8) .
RESULTS
Development and evaluation of the PCR test for cholera toxin subunit A gene. To develop the diagnostic PCR, we initially evaluated three different primer combinations and selected the primer set which most effectively amplified the cixA gene, as determined by the intensity of the amplicons after horizontal gel electrophoresis (data not shown). Primers CTX2 and CTX3 amplified a 564-bp region of the cixA gene from known toxigenic V. cholerae 01 control isolates.
Of 178 V. cholerae 01 isolates that were positive in the ELISA, 177 were initially positive by PCR (Tables 1 and 2) ; the one false-negative isolate was positive upon retesting, suggesting a possible problem with the first DNA extract. All 26 V cholerae 01 isolates that were negative in the ELISA were also negative by PCR (Tables 1 and 3 ).
E. coli strains known to produce an enterotoxin (LT) structurally similar to cholera toxin were tested in the PCR for cholera toxin (data not shown). Nineteen LT-producing strains were negative by PCR. Sixteen LT-positive E. coli strains generated a 400-bp amplicon when primers CTX2 and CTX3 were used at an annealing temperature of 50°C. This false-positive band was also generated by the CTX2 primer alone at 50°C. The nonspecific amplicon was not seen when the annealing temperature was adjusted to 60°C (Fig. 1) . Thirty-four A. hydrophila and Campylobacter strains that were reported to produce proteins similar to cholera toxin were negative by PCR (data not shown).
The cixA amplicon was produced directly from transport medium before subculture (Fig. 1) , and these results corresponded 100% with amplification after cultivation from a single colony and with ELISA results (data not shown). Three different thermocyclers were used, and all performed similarly with respect to cixA identification. One of the thermocyclers used a convenient 96-well microtiter plate format, and no cross contamination was observed.
Application of PCR to the Latin American cholera epidemic. Initially, suspected V. cholerae strains, which were sent or brought from Latin America, were serologically confirmed and assayed for cholera toxin by ELISA. After development of the PCR, all incoming isolates were first screened for the presence of cixA and were subsequently confirmed by serotyping and the ELISA (Table 1 ). There were no discrepancies between PCR and ELISA results for these strains.
DISCUSSION
The identification of cholera toxin production is an important step in the diagnosis of cholera, because only toxinproducing strains have been associated with severe, watery diarrhea and epidemics (9) . We have developed a PCR for the detection of the cholera toxin subunit A gene in V.
cholerae strains and, after evaluation, have applied it as a part of our routine identification procedure. Shirai et al. (17) also recently described a similar PCR assay for the cholera toxin gene. This PCR assay was applied successfully to both bacterial colonies and fecal samples from patients with suspected cholera.
An important factor in evaluating any DNA-based test is the specificity of the DNA sequences chosen for the gene and strains of interest. Several different bacterial species have been reported to possess toxins or proteins that are immunologically or genetically cross-reactive with cholera toxin (10, (12) (13) (14) 16) . A nonspecific reaction (e.g., DNA amplicon of the incorrect size) was observed for some of the enterotoxigenic E. coli strains at low annealing temperatures. These data are consistent with the concept of an LT gene family with various degrees of relatedness (9) . However, the PCR product was not homologous to ctxA and was eliminated by increasing the annealing temperature to 600C. Other bacterial species reported to produce proteins that cross-react with cholera toxin in immunologic tests were tested in the PCR and found to be negative. These isolates were also negative in the cholera toxin ELISA, indicating little homology with either cholera toxin or LT. The sequences of the amplicons of correct size were verified by restriction endonuclease digest patterns, and sequence verification or hybridization with internal probe should be part of a normal control procedure in a diagnostic PCR assay.
In the evaluation of an assay, it is important to confirm that a wide selection of organisms with the characteristic under examination give uniformly positive reactions. The V. cholerae strains analyzed in this study were isolated worldwide during the last 60 years (2) . The collection of known toxigenic and nontoxigenic control strains contained both classical and El Tor strains of Inaba and Ogawa serotypes. After evaluation with the well-characterized control strains in our study, the PCR was applied to unknown isolates sent to the Centers for Disease Control from suspected cases of cholera in Latin America during 1991 (5) (6) (7) . Epidemiologic investigations of the cholera outbreaks in Latin America included isolates from possible sources of transmission; thus, strains from food and water were also assayed.
An important advantage of the PCR over the ELISA is its rapidity. During the investigation of outbreaks of cholera, the presence of ctxA could be determined within 4 h, while the cholera toxin ELISA required at least 4 days. Important public health decisions were made on the basis of the PCR data, and control strategies were implemented, in some situations, within 24 h. The PCR also uses commercially available reagents and protocols; the automation of the process using a thermocycler ensures high reproducibility with respect to temperature and reaction time. The use of PCR is becoming increasingly important in the diagnosis of infectious diseases (12, 17) . It has the potential to be not only more rapid but also more specific and possibly more sensitive than currently available tests for the detection and identification of infectious agents. New PCR assays must be thoroughly controlled and evaluated before application to clinical specimens. We conclude that the PCR described above has proved to be a simple and fast alternative to immunologic assays that are currently employed in microbiology laboratories.
